ConductScience.org, home

Paper3905967

YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.

Piontek GE and 6 others. J Immunol, 1985. Cited by 167 papers, by iCite.

Cite this record

ConductScience Library. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage. Papers, record 3905967. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3905967

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
PubMed
Journal
J Immunol
PubMed
Year
1985
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
167
iCite
Relative citation ratio, by iCite
3.26
iCite
Revised in PubMed
2008-11-21
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Piontek GEG E
2Taniguchi KK
3Ljunggren HGH G
4Grönberg AA
5Kiessling RR
6Klein GG
7Kärre KK

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Genetic VariationMajor topic
H-2 AntigensMajor topic
Interferon Type IMajor topic
Killer Cells, NaturalMajor topic
Animals
Antilymphocyte Serum
Cell Line
Cytotoxicity, Immunologic
Mice
Neoplasm Transplantation
T-Lymphocytes, Cytotoxic
beta 2-Microglobulin

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
2 R01 CA 25250-07NCI NIH HHSUnited StatesR01CA252500PubMedNIH RePORTER
5 R01 CA 26782-05NCI NIH HHSUnited StatesR01CA267820PubMedNIH RePORTER
R01CA025250NIHNIH RePORTER
R01CA026782NIHNIH RePORTER

Download CSV of grants

Cited by46

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 167 citations.

PMIDTitleJournalYearIn PapersSource
39511139Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39511139PubMed
39201555A New Look at Immunogenetics of Pregnancy: Maternal Major Histocompatibility Complex Class I Educates Uterine Natural Killer Cells.Int J Mol Sci2024https://conductscience.org/library/papers/39201555PubMed
32903482Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells.Front Immunol2020https://conductscience.org/library/papers/32903482PubMed
32879472Human immunology and immunotherapy: main achievements and challenges.Cell Mol Immunol2021https://conductscience.org/library/papers/32879472PubMed
29466757Quiescent Tissue Stem Cells Evade Immune Surveillance.Immunity2018https://conductscience.org/library/papers/29466757PubMed
26911188Antitumour actions of interferons: implications for cancer therapy.Nat Rev Cancer2016https://conductscience.org/library/papers/26911188PubMed
26487683Agonist antibody that induces human malignant cells to kill one another.Proc Natl Acad Sci U S A2015https://conductscience.org/library/papers/26487683PubMed
24795726Activating killer cell Ig-like receptors in health and disease.Front Immunol2014https://conductscience.org/library/papers/24795726PubMed
22661698Impaired natural killer cell self-education and "missing-self" responses in Ly49-deficient mice.Blood2012https://conductscience.org/library/papers/22661698PubMed
22516959TLR9 and MyD88 are crucial for the development of protective immunity to malaria.J Immunol2012https://conductscience.org/library/papers/22516959PubMed
21475006StrataGraft skin substitute is well-tolerated and is not acutely immunogenic in patients with traumatic wounds: results from a prospective, randomized, controlled dose escalation trial.Ann Surg2011https://conductscience.org/library/papers/21475006PubMed
19949065The host defense peptide cathelicidin is required for NK cell-mediated suppression of tumor growth.J Immunol2010https://conductscience.org/library/papers/19949065PubMed
15378281NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin.Cancer Immunol Immunother2005https://conductscience.org/library/papers/15378281PubMed
14568980Elimination in vivo of developing T cells by natural killer cells.J Exp Med2003https://conductscience.org/library/papers/14568980PubMed
11819514On the cell biology of pit cells, the liver-specific NK cells.World J Gastroenterol2000https://conductscience.org/library/papers/11819514PubMed
11089888Biological properties associated with the enhanced lung-colonizing potential in a B16 murine melanoma line grown in a medium conditioned by syngeneic Corynebacterium parvum-elicited macrophages.Clin Exp Metastasis1999https://conductscience.org/library/papers/11089888PubMed
11050046Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma.Hepatology2000https://conductscience.org/library/papers/11050046PubMed
9858511Genetic control of natural killing and in vivo tumor elimination by the Chok locus.J Exp Med1998https://conductscience.org/library/papers/9858511PubMed
9482903Induction of transporter associated with antigen processing by interferon gamma confers endothelial cell cytoprotection against natural killer-mediated lysis.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9482903PubMed
8930665Flavivirus-induced up-regulation of MHC class I antigens; implications for the induction of CD8+ T-cell-mediated autoimmunity.Immunol Rev1996https://conductscience.org/library/papers/8930665PubMed

See all 46 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
B2M567PubTator's text mininghttps://conductscience.org/library/genes/567

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3905967

GET https://conductscience.org/api/papers/v1/3905967/cited_by?page=2